Cerus Endovascular

About:

Cerus Endovascular designs and develops interventional neuroradiology devices and delivery systems.

Top Investors: The North West Fund, Mid Atlantic Bio Angels, Tim Dempsey

Description:

Cerus Endovascular Ltd designs and develops interventional neuroradiology devices and delivery systems. The company develops e-clipse, an aneurysm occlusive device that addresses the current neurovascular aneurysm procedures attempted by surgical clipping, minimally invasive metal coils and liquid embolics. The company was founded in 2011 and is based in Oxford, United Kingdom.

Total Funding Amount:

1.5M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2011-01-01

Contact Email:

info(AT)cerusendo.com

Founders:

Todd Derbin

Number of Employees:

1-10

Last Funding Date:

2020-02-21

IPO Status:

Private

Industries: